Residency · Residency · Pediatrics

Immunization Principles and the Vaccine Schedule

Overview

Immunization is the single most effective public health intervention in pediatrics after clean water. The CDC childhood immunization schedule prevents an estimated 42,000 deaths and 20 million cases of disease per birth cohort in the United States. Pediatricians administer the majority of childhood vaccines and serve as the primary resource for vaccine education. Despite these benefits, national vaccination coverage remains suboptimal, with approximately 70% of children fully up-to-date by age 2. Vaccine hesitancy is a growing threat that the WHO has recognized as a top-ten global health concern.

Vaccine Immunology

Innate vs. Adaptive Immunity

Vaccines harness the adaptive immune system to generate immunologic memory. Humoral immunity involves B-cell production of antibodies (IgG and IgA) and is the primary mechanism by which most vaccines confer protection. Cell-mediated immunity through T-cell responses is particularly important for protection against intracellular pathogens such as tuberculosis and viral infections. The memory response ensures that subsequent pathogen exposure triggers a faster, higher-magnitude antibody production known as the anamnestic response.

Types of Vaccines

Live attenuated vaccines contain weakened pathogens that replicate in the host without causing disease. Examples include MMR, varicella, rotavirus, oral polio (OPV), BCG, live attenuated influenza vaccine (FluMist), and yellow fever. These generally produce strong, durable immunity with fewer doses but are contraindicated in immunocompromised patients and pregnancy. A minimum 28-day interval must separate two live injectable vaccines if they are not given simultaneously.

Inactivated or killed vaccines contain whole organisms or purified components that cannot replicate. Examples include IPV, hepatitis A, and injectable influenza. They require multiple doses and boosters for sustained immunity. Subunit or protein vaccines contain purified antigenic components, such as acellular pertussis (in DTaP/Tdap), hepatitis B (recombinant), HPV, and pneumococcal conjugate. Toxoid vaccines use inactivated toxins, as with tetanus and diphtheria.

Conjugate vaccines link polysaccharide antigens to protein carriers, converting a T-independent immune response to a T-dependent one. This approach is critical for children under 2 years who respond poorly to pure polysaccharide vaccines. Examples include PCV13/PCV15/PCV20, Hib, and meningococcal (MenACWY) vaccines. The mRNA vaccine platform encodes antigen proteins for host cell translation, as used in COVID-19 vaccines, enabling rapid development without live virus or DNA integration.

Herd Immunity

Herd immunity provides indirect protection of unvaccinated individuals when a sufficient proportion of the population is immune. The threshold varies by pathogen (measles, for example, requires 93-95% coverage). This concept is critical for protecting infants too young to be vaccinated and immunocompromised individuals who cannot receive live vaccines.

<image>Diagram illustrating the immune response to vaccination showing primary response (IgM followed by IgG) after first dose and the more rapid, higher-magnitude secondary (anamnestic) IgG response after booster dose, with memory B-cell and T-cell activation</image>

CDC Recommended Childhood Immunization Schedule

Birth to 15 Months

The schedule begins at birth with hepatitis B (dose 1). At 2 months, infants receive DTaP, IPV, Hib, PCV15/PCV20, rotavirus, and hepatitis B (dose 2). At 4 months, DTaP, IPV, Hib, PCV15/PCV20, and rotavirus are given. At 6 months, DTaP, PCV15/PCV20, rotavirus (third dose if RotaTeq), and hepatitis B (dose 3) are administered, along with the first annual influenza vaccine. At 12-15 months, MMR (dose 1), varicella (dose 1), hepatitis A (dose 1), PCV15/PCV20 booster, and Hib booster are given.

18 Months to 6 Years

The fourth dose of DTaP is given at 15-18 months. Hepatitis A dose 2 is given at 12-23 months (at least 6 months after dose 1). At 4-6 years, children receive the fifth dose of DTaP, fourth dose of IPV, second doses of MMR and varicella.

Adolescent Schedule

At 11-12 years, adolescents receive Tdap, MenACWY (dose 1), and begin the HPV series (2 doses if started before age 15, 3 doses if started at 15 or older). MenACWY booster is given at 16 years. MenB vaccination at 16-18 years involves shared clinical decision-making.

Key Combination Vaccines

Several combination vaccines reduce injection burden: Pediarix (DTaP + IPV + HepB), Pentacel (DTaP + IPV + Hib), Vaxelis (DTaP + IPV + HepB + Hib), and MMRV/ProQuad (MMR + Varicella, noting that use at 12-15 months carries slightly higher febrile seizure risk compared to separate MMR and varicella).

Catch-Up Immunization

The CDC catch-up schedule guides vaccination of children who have fallen behind. Key principles include respecting minimum intervals between doses and minimum ages for each dose. Doses given too early (before minimum age or interval) do not count and must be repeated. Invalid doses should be repeated at the next visit. A series never needs to be restarted regardless of time elapsed between doses. Common scenarios requiring catch-up include internationally adopted children, immigrant and refugee children, and children of vaccine-hesitant parents returning to vaccination.

Contraindications vs. Precautions

True Contraindications

Anaphylaxis to a vaccine component or prior dose of that vaccine is an absolute contraindication to further doses. Severe combined immunodeficiency or other severe immunodeficiency contraindicates all live vaccines. Pregnancy contraindicates live vaccines (MMR, varicella, LAIV). Encephalopathy within 7 days of a pertussis-containing vaccine contraindicates further pertussis vaccination.

Common Precautions (NOT Contraindications)

Moderate-to-severe acute illness warrants deferral until improvement. A history of Guillain-Barre syndrome within 6 weeks of a previous dose is a precaution. Immunosuppressive therapy is a precaution for live vaccines, requiring assessment of the degree of immunosuppression.

False Contraindications (Vaccines CAN Be Given)

Many commonly cited reasons for deferral are not valid contraindications. Vaccines can and should be given during mild illness with or without low-grade fever, during antibiotic therapy, after recent exposure to infectious disease, in premature infants (who should be vaccinated by chronologic age, not corrected age, with the exception of rotavirus timing in the NICU), during breastfeeding (all vaccines are safe), with a family history of adverse events, with egg allergy (MMR is grown in fibroblasts and is safe; influenza vaccine requires no special precautions regardless of egg allergy severity per ACIP 2023), and with a personal or family history of seizures.

<image>Table summarizing true contraindications versus common false contraindications (myths) for childhood vaccines, with columns for the vaccine, true contraindication, precautions, and commonly cited but invalid reasons to defer vaccination</image>

Vaccine Hesitancy and Communication

Understanding Vaccine Hesitancy

Vaccine hesitancy exists on a spectrum from vaccine-cautious individuals who want more information to vaccine-refusing individuals with firm ideological opposition. Drivers include safety concerns (the persistent autism myth, "too many too soon"), distrust of the pharmaceutical industry or government, religious or philosophical beliefs, and social media misinformation. The Wakefield study of 1998, though fraudulent and retracted, continues to have persistent cultural impact linking MMR to autism.

Communication Strategies

Presumptive language is the single most effective communication strategy. Rather than asking "Would you like to vaccinate today?" the provider should state "Today we'll be giving the 2-month vaccines." Studies by Opel et al. demonstrate higher acceptance rates with this approach. Motivational interviewing explores concerns with empathy, asks permission to share information, and avoids lecturing. Specific concerns should be addressed with clear, evidence-based responses. Acknowledging uncertainty while being transparent about the overwhelming evidence of safety and efficacy builds trust. Sharing personal experience ("I vaccinated my own children on schedule") and avoiding dismissiveness while maintaining the therapeutic relationship are important. Refusal should be documented with an informed refusal form, discussions documented, and the topic revisited at every visit. Patient dismissal is permitted but not encouraged by the AAP; exhausting all educational efforts first is preferred.

Alternative/Delayed Schedules

Alternative schedules such as Dr. Sears' are not endorsed by the AAP, CDC, or AAFP. Delayed schedules leave children vulnerable during peak disease risk periods. Spacing out vaccines has no evidence of improved safety and prolongs susceptibility. The recommended schedule has been extensively tested for safety and efficacy with combination dosing.

Special Populations

Preterm Infants

Preterm infants should be vaccinated at chronologic age using full doses. The exception is hepatitis B: if birth weight is below 2000g and the mother is HBsAg-negative, the first dose may be delayed until 1 month of age or hospital discharge. Rotavirus is given at chronologic age if the infant is medically stable and being discharged or has already been discharged.

Immunocompromised Children

Inactivated vaccines are generally safe and recommended for immunocompromised children. Live vaccines are contraindicated in severe immunodeficiency (SCID, active chemotherapy, high-dose corticosteroids at 2 mg/kg/day or greater, or 20 mg/day or more of prednisone for 14 or more days). Household contacts should receive all routine vaccines including live vaccines (except OPV, which is not used in the US). Revaccination schedules after hematopoietic stem cell transplant or solid organ transplant follow IDSA guidelines.

Asplenic/Hyposplenic Children

Children without functional spleens face increased risk from encapsulated organisms (Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae). They must receive PCV20 or PCV15 + PPSV23, MenACWY, MenB, and Hib vaccines, along with daily penicillin prophylaxis.

Clinical Pearls

Every clinical encounter is a vaccination opportunity, and immunization status should be checked at every visit, not just well-child checks. Presumptive language is the single most effective communication strategy for achieving vaccine acceptance. The egg allergy restriction for influenza and MMR vaccines has been essentially eliminated, and these vaccines should not be deferred for egg allergy. Combination vaccines reduce injection burden and improve on-time vaccination rates and should be used when available. Prematurity is not a reason to delay vaccines; preterm infants are at higher risk for vaccine-preventable diseases and should be vaccinated on schedule. Vaccine refusal conversations should be documented thoroughly while maintaining a non-judgmental, open-door policy.

Key Controversy: Parental Vaccine Refusal

An ethical tension exists between parental autonomy and the child's right to disease prevention. The AAP Committee on Bioethics strongly advocates for vaccination and permits but does not encourage patient dismissal. Arguments for dismissal include protection of vulnerable patients in the waiting room and liability concerns. Arguments against dismissal include loss of the therapeutic relationship, loss of the opportunity to eventually vaccinate, and disproportionate impact on underserved families. Best practice involves persistent, empathetic engagement at every visit while setting clear boundaries and keeping the door open.

References

• CDC. Recommended Child and Adolescent Immunization Schedule, United States 2024. Advisory Committee on Immunization Practices.
• Opel DJ, et al. The Architecture of Provider-Parent Vaccine Discussions at Health Supervision Visits. Pediatrics. 2013;132(6):1037-1046.
• Edwards KM, Hackell JM. Countering Vaccine Hesitancy. AAP Clinical Report. Pediatrics. 2016;138(3):e20162146.
• Kroger A, et al. General Best Practice Guidelines for Immunization. ACIP. Updated 2023.
• Plotkin SA, Orenstein WA, Offit PA. Vaccines. 7th Edition. Elsevier. 2018.
• AAP Committee on Infectious Diseases. Red Book: 2021-2024 Report of the Committee on Infectious Diseases.

Read this lecture as Markdown